Ari Waisman - Curriculum Vitae#

• 1983 - 1986 Degree programme, Life Sciences, B.Sc., Tel Aviv University, Tel Aviv, IL
  
• 1986 - 1988, Genetics, M.Sc., The Weizmann Institute of Science, Rehovot, IL
  
• Doctorate 1989 - 1994, Immunology, Ph.D, Mentor: Prof. E. Mozes, The Weizmann Institute of Science, Rehovot, IL
  

• Since 2011, W3 Univ. Prof. and Director, Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University, Mainz
  
• 2010 - 2011, Acting Director, Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University, Mainz
  
• 2005 - 2010, W2 Univ. Prof. in the I. Medical Department, University Medical Centre of the Johannes Gutenberg University, Mainz
  
• 2001 - 2005, Independent Group Leader, Laboratory for Molecular Immunology, Institute for Genetics, University of Cologne, Cologne, Germany
  
• 2000 - 2001, Research Associate, Department of Immunology, Institute for Genetics, University of Cologne, Cologne, Germany
  
• 1996 - 2000, Postdoctoral research with K. Rajewski, University of Cologne
  
• 1994 - 1996, Postdoctoral research with L. Steinman, The Weizmann Institute of Science, Israel

• Since 2023 Coordinator, TRR 355
  
• Since 2023 Member, Scientific Council of the Institute Pasteur, Paris
  
• Since 2022 Deputy Director, IMB International PhD Program
  
• Since 2022 Steering committee, SPP 2395 microglia
  
• Since 2019 Editorial Board, Neurology: Neuroimmunology and Neuroinflammation
  
• Since 2019 Director of the International Master of Biomedicine of the Universities of Mainz, Strasbourg and Luxembourg
  
• Since 2018 Steering Committee, SFB 1292
  
• Since 2018 Editor in Chief, Journal of Molecular Medicine
  
• Since 2018 Elected member of the board of German Society for Immunology (DGfI)
  
• 2016 Sobek Forschungspreis - International multiple sclerosis research prize
  
• 2015 - 2018 Coordinator, ERA-NET NEURON MELTRA-BBB
  
• Since 2015 Steering Committee, IMB International PhD Program
  
• 2015 - 2022 Editorial Board, Cellular Immunology
  
• Since 2014 Editorial Board, Acta Neuropathologica
  
• 2013 - 2016 Coordinator, EU ITN NeuroKine
  
• Since 2012 Advisory Board of Novartis on the role of IL-17A linking psoriasis with cardiovascular diseases
  
• Since 2012 Director, Master program in Biomedicine of the University of Mainz
  
• 2012 - 2016 Elected member of the International Advisory Board of the International Society of Neuroimmunology (ISNI)
  
• Since 2012 Steering Committee, TRR 128
  
• Since 2010 Associate Editor BMC Immunology
  
• 1998 - 2000 The European Community Long Term Fellowship
  
• 1996 - 1998 The Human Frontier Science Program Fellowship (HFSPO)